Effects of ketamine and N-methyl-d-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test

Neuroscience Letters

Volumn 566, Issue , 2014, Pages 172-176

  Owolabi, Rotimi Adegbenga ^a   Akanmu, Moses Atanda ^a   Adeyemi, Oluwole Isaac ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Antidepressant; Ketamine; N methyl d aspartate

Indexed keywords

FLUOXETINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID;

ADULT; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FACILITATION; FORCED SWIM TEST; IMMOBILITY; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM;

ANTIDEPRESSANT; KETAMINE; N-METHYL-D-ASPARTATE;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ANIMAL; DEPRESSION; FLUOXETINE; KETAMINE; MICE; N-METHYLASPARTATE; RECEPTORS, N-METHYL-D-ASPARTATE; SWIMMING; SYNAPTIC TRANSMISSION;

EID: 84897858614     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.01.015     Document Type: Article

References (36)

1. Baune B.T., Adrian I., Jacobi F. Medical disorders affect health outcome and general functioning depending on co-morbid major depression in the general population. Journal of Psychosomatic Research 2007, 62(2):109-118.
2. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 1988, 94:147-160.
3. Boyce-Rustay J.M., Holmes A. Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 2006, 31:2405-2414.
4. Calabrese F., Guidotti G., Molteni R., Racagni G., Mancini M., Riva M.A. Stress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatment. PLoS One 2012, 10.1371/journal.pone.0037916.
5. Cryan J., Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behaviour in genetically modified mice. Molecular Psychiatry 2004, 9:326-357.
6. D'Aquila P.S., Sias A., Gessa G.L., Serra G. The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole. European Journal of Pharmacology 1992, 224(2-3):199-202.
7. Davidson M., Shanley B., Wilce P. Increased NMDA-induced excitability during ethanol withdrawal: a behavioral and histological study. Brain Research 2000, 674(1):91-96.
8. De Montis M.G., Gambarana C., Meloni D., Taddei I., Tagliamonte A. Long-term imipramine effects are prevented by NMDA receptor blockade. Brain Research 1993, 606:63-67.
9. Feyder M., Camp M.C., Holmes A., Chen Y. Ethanol and NMDA receptor interactions: implications for pharmacotherapeutic treatments. Journal of Medical Sciences 2010, 30(1):3-10.
10. Follessa P., Ticku N. Receptor up-regulation: molecular studies in cultured mouse cortical neurons after chronic NMDA antagonist exposure. Journal of Neuroscience 1996, 16(7):2171-2178.
11. Kessler R.C., Akiskal H.S., Ames M., Birnbaum H., Greenberg P., Hirschfeld R.M. Prevalence and effects of mood disorders on work performance in a nationally representative sample of US workers. American Journal of Psychiatry 2006, 163(9):1561-1568.
12. Kim S.F. Increased serum glutamate level in depressed patients. Archiv fur Psychiatrie und Nervenkrankheiten 1982, 232:299-304.
13. Krozcka B.Z., Zieta A., Dudek D., Pilc A., Nowak G. Zinc exhibits antidepressant-like effect in forced swimming test in mice. Polish Journal of Pharmacology 2000, 52:402-406.
14. Kulkarni S.K., Mehta A.K. Purine nucleoside-mediated immobility in mice: reversal by antidepressants. Psychopharmacology 1985, 85:460-463.
15. Liu F., Patterson T.A., Sadovova N., Zhang X., Liu S., Zou X., Hang J., Paule M., Slikker W., Wang C. Ketamine-induced neuronal damage and altered NMDA receptor function in rat's primary forebrain culture. Toxicological Sciences 2012, 131:548-555.
16. Lucki I. The forced swimming test as a model for core and component behavioural effects of antidepressant drugs. Behavioural Pharmacology 1997, 8:523-532.
17. Maj J., Rogoz Z., Skuza G., Wedzony K. The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist. Journal of Neural Transmission 1996, 103:131-146.
18. Mjellem N., Lund A., Hole K. Reduction of NMDA-induced behaviour after acute and chronic desipramine in mice. Neuropharmacology 1993, 32:591-595.
19. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. Journal of Neurochemistry 1993, 60:1650-1657.
20. Nowak G., Legutkov B., Skolnick P., Popick P. Adaptation of cortical NMDA receptor by chronic treatment with specific 5HT reuptake inhibitors. European Journal of Pharmacology 1998, 342:367-370.
21. Nowak G., Szewczyk B., Wieronska J., Branski P., Paluchi A., Pilc A. Antidepressant-like effect of acute and chronic zinc in the forced swimming test and olfactory bulbectomy model in rats. Brain Research 2003, 61:159-164.
22. Paul I.A. Adaptation of the NMDA receptor complex following chronic antidepressant treatment. Journal of Pharmarmacology and Experimental Therapeutics 1994, 209:95-102.
23. Paul A. Adaptation of the NMDA receptor in the cortex following ECT or imipramine. European Journal of Pharmacology 1993, 247:305-311.
24. Paul A., Skolnick P. Glutamate and depression: clinical and preclinical studies. Annals of New York Academy of Science 2003, 1003:250-272.
25. Petrie X.A., Reid I.C., Stewart C.A. The N-methyl-d-aspartate receptor, synaptic plasticity, and depressive disorder: a critical review. Pharmacology and Therapeutics 2000, 87(1):11-25.
26. Popik P., Wrobel M., Nowak G. Chronic treatment with antidepressant affects glycine/NMDA receptor function: behavioural evidence. Neuropsychopharmacology 2000, 39:2278-2287.
27. Porsolt R., Bertin A., Jalfre M. Behavioural despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 1977, 229:327-336.
28. Reynolds R.J. Tricyclic antidepressants block NMDA receptor. Similarities to the action of zinc. British Journal of Pharmacology 1988, 95(1):95-102.
29. Ron D., Wang J. The N-methyl-d-aspartate receptor and alcohol addiction. The Biology of NMDA Receptor 2009, CRS Press, North Carolina, U.S.A., Chapter 4. V. Dongen, B. Raton (Eds.).
30. Skolnick P. Antidepressants of the new millennium. European Journal of Pharmacology 1999, 375:31-40.
31. Thase M.E., Haight B.R., Richard N., Rockett C.B., Mitton M., Modell J.G. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. Journal of Clinical Psychiatry 2005, 66(8):974-981.
32. Thomas M.S., Monagham D.T., Morrissett R.A. Evidence for a causative role of NMDA receptors in an in-vitro model of alcohol withdrawal hyper-excitability. Journal of Pharmacology and Experimental Therapeutics 1988, 287:87.
33. *D: implications for clinical practice. American Journal of Psychiatry 2006, 163(1):28-40.
34. Trullas R., Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant action. European Journal of Pharmacology 1990, 185:1-10.
35. Wang C., Sadovova N., Hotchkiss C., Fu X., Scallet A., Patterson T.A., Henig J., Paule M., Slikkers W. Blockade of NMDAR by ketamine produces loss of perinatal day 3 frontal cortical neurons in culture. Toxicological Sciences 2006, 91:192-201.
36. Saito H.H. Tricyclic antidepressants block NMDA responses and induction of long term potentiation in rat hippocampal slices. Neurophamacology 1992, 32(5):479-486.